Loading company
$16.38-3.5%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 12, 2026
Past performance
- 1W
- +4.3%
- 1M
- -21.1%
- 3M
- -21.0%
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Scribe Therapeutics Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$16.38-3.5%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 12, 2026